For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
The closing price of Origin Materials Inc (NASDAQ: ORGN) was $0.2 for the day, down -5.78% from the previous closing price of $0.21. In other words, the price has decreased by -$5.78 from its previous closing price. On the day, 4.17 million shares were traded. ORGN stock price reached its highest trading level at $0.208 during the session, while it also had its lowest trading level at $0.19.
Ratios:
Our analysis of ORGN’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 6.28 and its Current Ratio is at 6.33. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In the most recent recommendation for the company, BofA Securities on January 14, 2025, Downgraded its rating to Underperform and sets its target price to $1.50 from $2.50 previously.
On August 16, 2024, BofA Securities Upgraded its rating to Buy which previously was Neutral and also upped its target price recommendation from $1.35 to $3.
Craig Hallum Downgraded its Buy to Hold on August 11, 2023, while the target price for the stock was maintained at $2.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 26 ’25 when MATTHEW PLAVAN bought 40,000 shares for $0.20 per share.
Lee Joshua C. sold 35,000 shares of ORGN for $6,912 on Dec 29 ’25. The General Counsel now owns 606,884 shares after completing the transaction at $0.20 per share. On Dec 24 ’25, another insider, Lee Joshua C., who serves as the General Counsel of the company, sold 29,000 shares for $0.23 each. As a result, the insider received 6,609 and left with 641,884 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ORGN now has a Market Capitalization of 29791636 and an Enterprise Value of -18875364. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.19 while its Price-to-Book (P/B) ratio in mrq is 0.10. Its current Enterprise Value per Revenue stands at -0.751 whereas that against EBITDA is 0.358.
Stock Price History:
The Beta on a monthly basis for ORGN is 0.93, which has changed by -0.8272727 over the last 52 weeks, in comparison to a change of 0.17673707 over the same period for the S&P500. Over the past 52 weeks, ORGN has reached a high of $1.36, while it has fallen to a 52-week low of $0.19. The 50-Day Moving Average of the stock is -57.92%, while the 200-Day Moving Average is calculated to be -65.33%.
Shares Statistics:
ORGN traded an average of 1.58M shares per day over the past three months and 3943350 shares per day over the past ten days. A total of 150.53M shares are outstanding, with a floating share count of 136.56M. Insiders hold about 9.65% of the company’s shares, while institutions hold 10.86% stake in the company. Shares short for ORGN as of 1765756800 were 4123860 with a Short Ratio of 2.62, compared to 1763078400 on 3601424. Therefore, it implies a Short% of Shares Outstanding of 4123860 and a Short% of Float of 2.77.
